{
    "2018-03-12": [
        [
            {
                "time": "2018-03-12",
                "original_text": "乐普医疗：预计一季度净利润同比增长30.0%-40%",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "乐普医疗2017年度净利8.99亿元 同比增长32% 拟10派1.27元",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "净利",
                        "同比增长",
                        "分红"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "乐普医疗：参股子公司PD1产品获批临床，肿瘤布局进展加速",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "PD1",
                        "临床",
                        "肿瘤",
                        "布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "[领先大市-A评级]医药行业每周观点：业绩超预期和行业筑底完成驱动板块上涨显著 建议重点关注意药板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "业绩超预期",
                        "板块上涨"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "券商评级:沪指三连阳站稳3300 9股蓄势待发",
                "features": {
                    "keywords": [
                        "券商评级",
                        "沪指",
                        "三连阳"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "[买入评级]乐普医疗(300003)动态跟踪报告：君实生物PD-1单抗新药申请获得受理 抗肿瘤产品线进入收获期",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "君实生物",
                        "PD-1",
                        "单抗",
                        "新药申请",
                        "抗肿瘤"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "【中信建投证券】每日精华推荐（2018.03.12）",
                "features": {
                    "keywords": [
                        "中信建投证券",
                        "精华推荐"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "【医药】医药行业3月月报——仍存结构性差异，优选边际改善主线",
                "features": {
                    "keywords": [
                        "医药行业",
                        "月报",
                        "结构性差异",
                        "边际改善"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-12",
                "original_text": "医药生物行业周报:医药关注提升,聚焦创新和国际化",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "创新",
                        "国际化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}